Acute myocardial infarction complicating prosthetic valve thrombosis in a man with mechanical aortic valve replacement and remote reconstructions of the ascending aorta
AI-generated summary
Joshua Paul Coates, aged 49, died from acute myocardial infarction complicating prosthetic valve thrombosis following mechanical aortic valve replacement. Post-mortem examination revealed a large blood clot obstructing his aortic graft and left ventricular outflow tract. Critical clinical lessons emerged: Mr Coates' INR levels (1.6–2.0) fell below the target range (2.5–3.5) for mechanical valves, inadequate anticoagulation significantly increasing thrombosis risk. Systemic failures included incomplete discharge summaries not conveying anticoagulation details to community providers, poor handover between Monash Health and Dorevitch Pathology regarding warfarin management, and delayed patient registration with missing clinical information. The coroner found no single shortcoming would have prevented death in isolation, but the combination of communication failures, incomplete information transfer, and suboptimal anticoagulation management contributed to adverse outcomes. Recommendations focused on improving discharge processes, ensuring accurate patient information capture, and establishing mechanisms for patients to escalate clinical concerns.
AI-generated summary and tagging — may contain inaccuracies; refer to original finding for legal purposes. Report an inaccuracy.
Specialties
cardiothoracic surgerycardiologypathologygeneral practiceemergency medicineintensive care
ascending aorta and aortic arch replacement with Dacron graftredo St Jude mechanical Bentall's procedurecardiac catheterisationpercutaneous coronary interventiondrug-eluting stent insertionextracorporeal membrane oxygenation
Contributing factors
Inadequate anticoagulation with sub-therapeutic INR levels
Incomplete discharge summary not conveying anticoagulation management details
Poor clinical communication between Monash Health and Dorevitch Pathology
Delay in patient registration with Warfarin Management System
Missing clinical information in pathology request including dosing history and indication for clexane bridging
Lack of understanding of external pathology service processes by junior medical staff
Failure to confirm GP details before discharge
Lack of adequate patient information regarding warfarin management registration
Complex anatomy from previous aortic reconstructions limiting coronary angiography options at referral hospital
Transient thrombotic occlusion of coronary ostia causing fluctuating symptoms
Coroner's recommendations
Monash Health and Dorevitch Pathology should review clinical information system processes for discharged patients and outpatients to ensure systems are user-friendly for staff to accurately capture patient information
Systems should be consumer-friendly to allow patients and carers to swiftly raise clinical concerns about ongoing care
Review Enoxaparin Medication Profile, Warfarin Medication Profile and Antiplatelet and Anticoagulant Medicines – Post Procedural Management Implementation Tool to ensure best practice standards
Optimise and embed the process for anticoagulation of post-operative AVR patients with effective and coordinated discharge planning
Explore feasibility of providing warfarin management service to patients 7-10 days post-discharge to ensure consistent warfarin management and transparent escalation process
Ensure patient GP details are confirmed before discharge and updated in iPM system to ensure accurate distribution of discharge summaries
Ensure process for referring and accepting cardiology and cardiothoracic surgery patients to Victorian Heart Hospital is communicated internally and to referring networks
Implement program to share learnings with Cardiothoracic Surgery Department medical staff
Implement and promote easier pre-registration of new patients on warfarin at Dorevitch Pathology
Conduct refresher training sessions for pathologist teams on warfarin management
Ensure complaints and queries regarding warfarin management are escalated to relevant clinical teams
This page reproduces or summarises information from publicly available findings published by Australian coroners' courts. Coronial is an independent educational resource and is not affiliated with, endorsed by, or acting on behalf of any coronial court or government body.
Content may be incomplete, reformatted, or summarised. Some material may have been redacted or restricted by court order or privacy requirements. Always refer to the original court publication for the authoritative record.
Copyright in original materials remains with the relevant government jurisdiction. AI-generated summaries and tagging are for educational purposes only, may contain inaccuracies, and must not be treated as legal documents. We welcome feedback for correction — report an inaccuracy here.